weight gain with glp 1 GLP-1 Agonists Loss Drugs Market Report, 2025-2030 Learn from this Busy Mom's

While GLP-1s have, for years, been a prescribed treatment for type 2 diabetes, they now are an FDA-approved weight-loss drug that also reduce the risk of certain cancers, heart disease, cognitive decline and more

This article does not argue for or against the drug class

12 Likes Intermittent (oral) Rybelsus / Semaglutide use in healthy individuals

The health conditions that qualify you at the lower BMI thresholds are: Heart failure with preserved ejection fraction (required for BMI 30 pathway) Uncontrolled hypertension despite two antihypertensive medications (BMI 30 pathway) Chronic kidney disease stage 3a or above (BMI 30 pathway) Prediabetes, as defined by American Diabetes Association guidelines (BMI 27 pathway) Previous heart attack (myocardial infarction) (BMI 27 pathway) Previous stroke (BMI 27 pathway) Symptomatic peripheral artery disease (BMI 27 pathway) What changes on July 1, 2026